星空体育官方入口网站网址大全-登录入口官网

[GetPortalCommentsPageByObjectIdResponse(id=2144442, encodeId=6f4121444420d, content=偏重的研究方向：药理学;药物 经验分享：请问下投过稿的各位，什么时候有稿件号呢？这个期刊不是投完稿马上自动生成的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26f41991655, createdName=少吃一口, createdTime=Sat Jun 24 02:44:23 CST 2023, time=2023-06-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=574549, encodeId=79eb5e4549ff, content=沈药校友前来报道。lx815744820 2018-03-16 13:22:00 发表: 沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, beContent=lx815744820 2018-03-16 13:22:00 发表: 沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/08/79501b6bee1cbc70be24e0f5456a45c8.jpg, createdBy=0f665157065, createdName=Te Fiur, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233601, encodeId=07e21233601bc, content=偏重的研究方向：药物 经验分享：中药单体通路可投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72fc5543994, createdName=嘎嘎S, createdTime=Wed Jul 20 13:13:39 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107096, encodeId=2a92110e0963f, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004505, encodeId=4a281004505a4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理学;药物;药剂学 经验分享：Asian J Pharm Sci自2017年被SCIE收录，收录内容从2015年第1期开始，是中国第一个被SCIE收录的药剂学学术期刊。荣获中国高校百佳科技期刊、中国最具国际影响力期刊和辽宁省高校优秀期刊等多个奖项，2019年入选中国科技期刊卓越行动计划。 Asian J Pharm Sci文章收录全文以开放式存取模式在ScienceDirect上在线发布，论文发表不收版面费。期刊主页： http://www.elsevier.com/locate/ajps 全文免费下载： http://www.sciencedirect.com/science/journal/18180876 免费在线投稿： https://www.editorialmanager.com/ajops/default.aspx , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210802/d0f2acf2ffeb4b67b3c4d9e86115fc29.jpeg, type=image, width=733, height=545)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Mon Aug 02 00:29:56 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601901, encodeId=cdb4601901f9, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：This journal is a peer reviewed, subsidized open access journal where Shenyang Pharmaceutical University pays the OA fee. Authors do not have to pay any open access publication fee (作者无需付任何出版费用)., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Jun 09 17:46:17 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585728, encodeId=73dd585e2861, content=版面费大概多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553742, encodeId=a8a1553e428b, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e7b1636618, createdName=lx815744820, createdTime=Fri Mar 16 13:22:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550560, encodeId=62955505600b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：这是沈阳药科大学出版的英文药理学杂志，中国人办的，要多支持投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jan 02 16:44:00 CST 2018, time=2018-01-02, status=1, ipAttribution=)]

2023-06-24 少吃一口来自四川省

偏重的研究方向：药理学;药物
经验分享：请问下投过稿的各位，什么时候有稿件号呢？这个期刊不是投完稿马上自动生成的

36 0

[GetPortalCommentsPageByObjectIdResponse(id=2144442, encodeId=6f4121444420d, content=偏重的研究方向：药理学;药物 经验分享：请问下投过稿的各位，什么时候有稿件号呢？这个期刊不是投完稿马上自动生成的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26f41991655, createdName=少吃一口, createdTime=Sat Jun 24 02:44:23 CST 2023, time=2023-06-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=574549, encodeId=79eb5e4549ff, content=沈药校友前来报道。lx815744820 2018-03-16 13:22:00 发表: 沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, beContent=lx815744820 2018-03-16 13:22:00 发表: 沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/08/79501b6bee1cbc70be24e0f5456a45c8.jpg, createdBy=0f665157065, createdName=Te Fiur, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233601, encodeId=07e21233601bc, content=偏重的研究方向：药物 经验分享：中药单体通路可投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72fc5543994, createdName=嘎嘎S, createdTime=Wed Jul 20 13:13:39 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107096, encodeId=2a92110e0963f, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004505, encodeId=4a281004505a4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理学;药物;药剂学 经验分享：Asian J Pharm Sci自2017年被SCIE收录，收录内容从2015年第1期开始，是中国第一个被SCIE收录的药剂学学术期刊。荣获中国高校百佳科技期刊、中国最具国际影响力期刊和辽宁省高校优秀期刊等多个奖项，2019年入选中国科技期刊卓越行动计划。 Asian J Pharm Sci文章收录全文以开放式存取模式在ScienceDirect上在线发布，论文发表不收版面费。期刊主页： http://www.elsevier.com/locate/ajps 全文免费下载： http://www.sciencedirect.com/science/journal/18180876 免费在线投稿： https://www.editorialmanager.com/ajops/default.aspx , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210802/d0f2acf2ffeb4b67b3c4d9e86115fc29.jpeg, type=image, width=733, height=545)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Mon Aug 02 00:29:56 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601901, encodeId=cdb4601901f9, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：This journal is a peer reviewed, subsidized open access journal where Shenyang Pharmaceutical University pays the OA fee. Authors do not have to pay any open access publication fee (作者无需付任何出版费用)., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Jun 09 17:46:17 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585728, encodeId=73dd585e2861, content=版面费大概多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553742, encodeId=a8a1553e428b, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e7b1636618, createdName=lx815744820, createdTime=Fri Mar 16 13:22:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550560, encodeId=62955505600b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：这是沈阳药科大学出版的英文药理学杂志，中国人办的，要多支持投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jan 02 16:44:00 CST 2018, time=2018-01-02, status=1, ipAttribution=)]

2019-08-08 Te Fiur

沈药校友前来报道。lx815744820 2018-03-16 13:22:00 发表:
沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好

lx815744820 2018-03-16 13:22:00 发表: 沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好

195 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2144442, encodeId=6f4121444420d, content=偏重的研究方向：药理学;药物 经验分享：请问下投过稿的各位，什么时候有稿件号呢？这个期刊不是投完稿马上自动生成的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26f41991655, createdName=少吃一口, createdTime=Sat Jun 24 02:44:23 CST 2023, time=2023-06-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=574549, encodeId=79eb5e4549ff, content=沈药校友前来报道。lx815744820 2018-03-16 13:22:00 发表: 沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, beContent=lx815744820 2018-03-16 13:22:00 发表: 沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/08/79501b6bee1cbc70be24e0f5456a45c8.jpg, createdBy=0f665157065, createdName=Te Fiur, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233601, encodeId=07e21233601bc, content=偏重的研究方向：药物 经验分享：中药单体通路可投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72fc5543994, createdName=嘎嘎S, createdTime=Wed Jul 20 13:13:39 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107096, encodeId=2a92110e0963f, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004505, encodeId=4a281004505a4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理学;药物;药剂学 经验分享：Asian J Pharm Sci自2017年被SCIE收录，收录内容从2015年第1期开始，是中国第一个被SCIE收录的药剂学学术期刊。荣获中国高校百佳科技期刊、中国最具国际影响力期刊和辽宁省高校优秀期刊等多个奖项，2019年入选中国科技期刊卓越行动计划。 Asian J Pharm Sci文章收录全文以开放式存取模式在ScienceDirect上在线发布，论文发表不收版面费。期刊主页： http://www.elsevier.com/locate/ajps 全文免费下载： http://www.sciencedirect.com/science/journal/18180876 免费在线投稿： https://www.editorialmanager.com/ajops/default.aspx , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210802/d0f2acf2ffeb4b67b3c4d9e86115fc29.jpeg, type=image, width=733, height=545)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Mon Aug 02 00:29:56 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601901, encodeId=cdb4601901f9, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：This journal is a peer reviewed, subsidized open access journal where Shenyang Pharmaceutical University pays the OA fee. Authors do not have to pay any open access publication fee (作者无需付任何出版费用)., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Jun 09 17:46:17 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585728, encodeId=73dd585e2861, content=版面费大概多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553742, encodeId=a8a1553e428b, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e7b1636618, createdName=lx815744820, createdTime=Fri Mar 16 13:22:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550560, encodeId=62955505600b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：这是沈阳药科大学出版的英文药理学杂志，中国人办的，要多支持投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jan 02 16:44:00 CST 2018, time=2018-01-02, status=1, ipAttribution=)]

2022-07-20 嘎嘎S

偏重的研究方向：药物
经验分享：中药单体通路可投吗

57 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2144442, encodeId=6f4121444420d, content=偏重的研究方向：药理学;药物 经验分享：请问下投过稿的各位，什么时候有稿件号呢？这个期刊不是投完稿马上自动生成的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26f41991655, createdName=少吃一口, createdTime=Sat Jun 24 02:44:23 CST 2023, time=2023-06-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=574549, encodeId=79eb5e4549ff, content=沈药校友前来报道。lx815744820 2018-03-16 13:22:00 发表: 沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, beContent=lx815744820 2018-03-16 13:22:00 发表: 沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/08/79501b6bee1cbc70be24e0f5456a45c8.jpg, createdBy=0f665157065, createdName=Te Fiur, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233601, encodeId=07e21233601bc, content=偏重的研究方向：药物 经验分享：中药单体通路可投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72fc5543994, createdName=嘎嘎S, createdTime=Wed Jul 20 13:13:39 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107096, encodeId=2a92110e0963f, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004505, encodeId=4a281004505a4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理学;药物;药剂学 经验分享：Asian J Pharm Sci自2017年被SCIE收录，收录内容从2015年第1期开始，是中国第一个被SCIE收录的药剂学学术期刊。荣获中国高校百佳科技期刊、中国最具国际影响力期刊和辽宁省高校优秀期刊等多个奖项，2019年入选中国科技期刊卓越行动计划。 Asian J Pharm Sci文章收录全文以开放式存取模式在ScienceDirect上在线发布，论文发表不收版面费。期刊主页： http://www.elsevier.com/locate/ajps 全文免费下载： http://www.sciencedirect.com/science/journal/18180876 免费在线投稿： https://www.editorialmanager.com/ajops/default.aspx , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210802/d0f2acf2ffeb4b67b3c4d9e86115fc29.jpeg, type=image, width=733, height=545)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Mon Aug 02 00:29:56 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601901, encodeId=cdb4601901f9, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：This journal is a peer reviewed, subsidized open access journal where Shenyang Pharmaceutical University pays the OA fee. Authors do not have to pay any open access publication fee (作者无需付任何出版费用)., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Jun 09 17:46:17 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585728, encodeId=73dd585e2861, content=版面费大概多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553742, encodeId=a8a1553e428b, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e7b1636618, createdName=lx815744820, createdTime=Fri Mar 16 13:22:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550560, encodeId=62955505600b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：这是沈阳药科大学出版的英文药理学杂志，中国人办的，要多支持投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jan 02 16:44:00 CST 2018, time=2018-01-02, status=1, ipAttribution=)]

2021-12-28 MS68862005

ORCIDID是什么？怎么注册？

54 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2144442, encodeId=6f4121444420d, content=偏重的研究方向：药理学;药物 经验分享：请问下投过稿的各位，什么时候有稿件号呢？这个期刊不是投完稿马上自动生成的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26f41991655, createdName=少吃一口, createdTime=Sat Jun 24 02:44:23 CST 2023, time=2023-06-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=574549, encodeId=79eb5e4549ff, content=沈药校友前来报道。lx815744820 2018-03-16 13:22:00 发表: 沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, beContent=lx815744820 2018-03-16 13:22:00 发表: 沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/08/79501b6bee1cbc70be24e0f5456a45c8.jpg, createdBy=0f665157065, createdName=Te Fiur, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233601, encodeId=07e21233601bc, content=偏重的研究方向：药物 经验分享：中药单体通路可投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72fc5543994, createdName=嘎嘎S, createdTime=Wed Jul 20 13:13:39 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107096, encodeId=2a92110e0963f, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004505, encodeId=4a281004505a4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理学;药物;药剂学 经验分享：Asian J Pharm Sci自2017年被SCIE收录，收录内容从2015年第1期开始，是中国第一个被SCIE收录的药剂学学术期刊。荣获中国高校百佳科技期刊、中国最具国际影响力期刊和辽宁省高校优秀期刊等多个奖项，2019年入选中国科技期刊卓越行动计划。 Asian J Pharm Sci文章收录全文以开放式存取模式在ScienceDirect上在线发布，论文发表不收版面费。期刊主页： http://www.elsevier.com/locate/ajps 全文免费下载： http://www.sciencedirect.com/science/journal/18180876 免费在线投稿： https://www.editorialmanager.com/ajops/default.aspx , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210802/d0f2acf2ffeb4b67b3c4d9e86115fc29.jpeg, type=image, width=733, height=545)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Mon Aug 02 00:29:56 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601901, encodeId=cdb4601901f9, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：This journal is a peer reviewed, subsidized open access journal where Shenyang Pharmaceutical University pays the OA fee. Authors do not have to pay any open access publication fee (作者无需付任何出版费用)., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Jun 09 17:46:17 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585728, encodeId=73dd585e2861, content=版面费大概多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553742, encodeId=a8a1553e428b, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e7b1636618, createdName=lx815744820, createdTime=Fri Mar 16 13:22:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550560, encodeId=62955505600b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：这是沈阳药科大学出版的英文药理学杂志，中国人办的，要多支持投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jan 02 16:44:00 CST 2018, time=2018-01-02, status=1, ipAttribution=)]

2021-08-02 小小医者

精彩评论，需要您登录查看

78 0

[GetPortalCommentsPageByObjectIdResponse(id=2144442, encodeId=6f4121444420d, content=偏重的研究方向：药理学;药物 经验分享：请问下投过稿的各位，什么时候有稿件号呢？这个期刊不是投完稿马上自动生成的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26f41991655, createdName=少吃一口, createdTime=Sat Jun 24 02:44:23 CST 2023, time=2023-06-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=574549, encodeId=79eb5e4549ff, content=沈药校友前来报道。lx815744820 2018-03-16 13:22:00 发表: 沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, beContent=lx815744820 2018-03-16 13:22:00 发表: 沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/08/79501b6bee1cbc70be24e0f5456a45c8.jpg, createdBy=0f665157065, createdName=Te Fiur, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233601, encodeId=07e21233601bc, content=偏重的研究方向：药物 经验分享：中药单体通路可投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72fc5543994, createdName=嘎嘎S, createdTime=Wed Jul 20 13:13:39 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107096, encodeId=2a92110e0963f, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004505, encodeId=4a281004505a4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理学;药物;药剂学 经验分享：Asian J Pharm Sci自2017年被SCIE收录，收录内容从2015年第1期开始，是中国第一个被SCIE收录的药剂学学术期刊。荣获中国高校百佳科技期刊、中国最具国际影响力期刊和辽宁省高校优秀期刊等多个奖项，2019年入选中国科技期刊卓越行动计划。 Asian J Pharm Sci文章收录全文以开放式存取模式在ScienceDirect上在线发布，论文发表不收版面费。期刊主页： http://www.elsevier.com/locate/ajps 全文免费下载： http://www.sciencedirect.com/science/journal/18180876 免费在线投稿： https://www.editorialmanager.com/ajops/default.aspx , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210802/d0f2acf2ffeb4b67b3c4d9e86115fc29.jpeg, type=image, width=733, height=545)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Mon Aug 02 00:29:56 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601901, encodeId=cdb4601901f9, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：This journal is a peer reviewed, subsidized open access journal where Shenyang Pharmaceutical University pays the OA fee. Authors do not have to pay any open access publication fee (作者无需付任何出版费用)., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Jun 09 17:46:17 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585728, encodeId=73dd585e2861, content=版面费大概多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553742, encodeId=a8a1553e428b, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e7b1636618, createdName=lx815744820, createdTime=Fri Mar 16 13:22:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550560, encodeId=62955505600b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：这是沈阳药科大学出版的英文药理学杂志，中国人办的，要多支持投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jan 02 16:44:00 CST 2018, time=2018-01-02, status=1, ipAttribution=)]

2020-06-09 lovetcm

审稿速度:2.0 | 投稿命中率:75.0
经验分享：This journal is a peer reviewed, subsidized open access journal where Shenyang Pharmaceutical University pays the OA fee. Authors do not have to pay any open access publication fee (作者无需付任何出版费用).

145 0

[GetPortalCommentsPageByObjectIdResponse(id=2144442, encodeId=6f4121444420d, content=偏重的研究方向：药理学;药物 经验分享：请问下投过稿的各位，什么时候有稿件号呢？这个期刊不是投完稿马上自动生成的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26f41991655, createdName=少吃一口, createdTime=Sat Jun 24 02:44:23 CST 2023, time=2023-06-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=574549, encodeId=79eb5e4549ff, content=沈药校友前来报道。lx815744820 2018-03-16 13:22:00 发表: 沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, beContent=lx815744820 2018-03-16 13:22:00 发表: 沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/08/79501b6bee1cbc70be24e0f5456a45c8.jpg, createdBy=0f665157065, createdName=Te Fiur, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233601, encodeId=07e21233601bc, content=偏重的研究方向：药物 经验分享：中药单体通路可投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72fc5543994, createdName=嘎嘎S, createdTime=Wed Jul 20 13:13:39 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107096, encodeId=2a92110e0963f, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004505, encodeId=4a281004505a4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理学;药物;药剂学 经验分享：Asian J Pharm Sci自2017年被SCIE收录，收录内容从2015年第1期开始，是中国第一个被SCIE收录的药剂学学术期刊。荣获中国高校百佳科技期刊、中国最具国际影响力期刊和辽宁省高校优秀期刊等多个奖项，2019年入选中国科技期刊卓越行动计划。 Asian J Pharm Sci文章收录全文以开放式存取模式在ScienceDirect上在线发布，论文发表不收版面费。期刊主页： http://www.elsevier.com/locate/ajps 全文免费下载： http://www.sciencedirect.com/science/journal/18180876 免费在线投稿： https://www.editorialmanager.com/ajops/default.aspx , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210802/d0f2acf2ffeb4b67b3c4d9e86115fc29.jpeg, type=image, width=733, height=545)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Mon Aug 02 00:29:56 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601901, encodeId=cdb4601901f9, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：This journal is a peer reviewed, subsidized open access journal where Shenyang Pharmaceutical University pays the OA fee. Authors do not have to pay any open access publication fee (作者无需付任何出版费用)., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Jun 09 17:46:17 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585728, encodeId=73dd585e2861, content=版面费大概多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553742, encodeId=a8a1553e428b, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e7b1636618, createdName=lx815744820, createdTime=Fri Mar 16 13:22:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550560, encodeId=62955505600b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：这是沈阳药科大学出版的英文药理学杂志，中国人办的，要多支持投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jan 02 16:44:00 CST 2018, time=2018-01-02, status=1, ipAttribution=)]

2020-03-02 146f6ef6m90(暂无昵称)

版面费大概多少啊

174 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2144442, encodeId=6f4121444420d, content=偏重的研究方向：药理学;药物 经验分享：请问下投过稿的各位，什么时候有稿件号呢？这个期刊不是投完稿马上自动生成的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26f41991655, createdName=少吃一口, createdTime=Sat Jun 24 02:44:23 CST 2023, time=2023-06-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=574549, encodeId=79eb5e4549ff, content=沈药校友前来报道。lx815744820 2018-03-16 13:22:00 发表: 沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, beContent=lx815744820 2018-03-16 13:22:00 发表: 沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/08/79501b6bee1cbc70be24e0f5456a45c8.jpg, createdBy=0f665157065, createdName=Te Fiur, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233601, encodeId=07e21233601bc, content=偏重的研究方向：药物 经验分享：中药单体通路可投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72fc5543994, createdName=嘎嘎S, createdTime=Wed Jul 20 13:13:39 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107096, encodeId=2a92110e0963f, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004505, encodeId=4a281004505a4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理学;药物;药剂学 经验分享：Asian J Pharm Sci自2017年被SCIE收录，收录内容从2015年第1期开始，是中国第一个被SCIE收录的药剂学学术期刊。荣获中国高校百佳科技期刊、中国最具国际影响力期刊和辽宁省高校优秀期刊等多个奖项，2019年入选中国科技期刊卓越行动计划。 Asian J Pharm Sci文章收录全文以开放式存取模式在ScienceDirect上在线发布，论文发表不收版面费。期刊主页： http://www.elsevier.com/locate/ajps 全文免费下载： http://www.sciencedirect.com/science/journal/18180876 免费在线投稿： https://www.editorialmanager.com/ajops/default.aspx , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210802/d0f2acf2ffeb4b67b3c4d9e86115fc29.jpeg, type=image, width=733, height=545)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Mon Aug 02 00:29:56 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601901, encodeId=cdb4601901f9, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：This journal is a peer reviewed, subsidized open access journal where Shenyang Pharmaceutical University pays the OA fee. Authors do not have to pay any open access publication fee (作者无需付任何出版费用)., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Jun 09 17:46:17 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585728, encodeId=73dd585e2861, content=版面费大概多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553742, encodeId=a8a1553e428b, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e7b1636618, createdName=lx815744820, createdTime=Fri Mar 16 13:22:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550560, encodeId=62955505600b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：这是沈阳药科大学出版的英文药理学杂志，中国人办的，要多支持投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jan 02 16:44:00 CST 2018, time=2018-01-02, status=1, ipAttribution=)]

2018-03-16 lx815744820

审稿速度:1.0 | 投稿命中率:50.0
经验分享：沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好

335 0

[GetPortalCommentsPageByObjectIdResponse(id=2144442, encodeId=6f4121444420d, content=偏重的研究方向：药理学;药物 经验分享：请问下投过稿的各位，什么时候有稿件号呢？这个期刊不是投完稿马上自动生成的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26f41991655, createdName=少吃一口, createdTime=Sat Jun 24 02:44:23 CST 2023, time=2023-06-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=574549, encodeId=79eb5e4549ff, content=沈药校友前来报道。lx815744820 2018-03-16 13:22:00 发表: 沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, beContent=lx815744820 2018-03-16 13:22:00 发表: 沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/08/79501b6bee1cbc70be24e0f5456a45c8.jpg, createdBy=0f665157065, createdName=Te Fiur, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233601, encodeId=07e21233601bc, content=偏重的研究方向：药物 经验分享：中药单体通路可投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72fc5543994, createdName=嘎嘎S, createdTime=Wed Jul 20 13:13:39 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107096, encodeId=2a92110e0963f, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004505, encodeId=4a281004505a4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理学;药物;药剂学 经验分享：Asian J Pharm Sci自2017年被SCIE收录，收录内容从2015年第1期开始，是中国第一个被SCIE收录的药剂学学术期刊。荣获中国高校百佳科技期刊、中国最具国际影响力期刊和辽宁省高校优秀期刊等多个奖项，2019年入选中国科技期刊卓越行动计划。 Asian J Pharm Sci文章收录全文以开放式存取模式在ScienceDirect上在线发布，论文发表不收版面费。期刊主页： http://www.elsevier.com/locate/ajps 全文免费下载： http://www.sciencedirect.com/science/journal/18180876 免费在线投稿： https://www.editorialmanager.com/ajops/default.aspx , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210802/d0f2acf2ffeb4b67b3c4d9e86115fc29.jpeg, type=image, width=733, height=545)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Mon Aug 02 00:29:56 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601901, encodeId=cdb4601901f9, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：This journal is a peer reviewed, subsidized open access journal where Shenyang Pharmaceutical University pays the OA fee. Authors do not have to pay any open access publication fee (作者无需付任何出版费用)., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Jun 09 17:46:17 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585728, encodeId=73dd585e2861, content=版面费大概多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553742, encodeId=a8a1553e428b, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：沈阳药科大学药剂学一手筹办的，希望大家多多支持，希望沈药越来越好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e7b1636618, createdName=lx815744820, createdTime=Fri Mar 16 13:22:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550560, encodeId=62955505600b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：这是沈阳药科大学出版的英文药理学杂志，中国人办的，要多支持投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jan 02 16:44:00 CST 2018, time=2018-01-02, status=1, ipAttribution=)]

2018-01-02 lovetcm

审稿速度:3.0 | 投稿命中率:75.0
经验分享：这是沈阳药科大学出版的英文药理学杂志，中国人办的，要多支持投稿！

364 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务